Bank of Nova Scotia »

Amylyx Pharmaceuticals shares owned by Bank of Nova Scotia

Quarter-by-quarter ownership of Amylyx Pharmaceuticals (AMLX) shares owned by Bank of Nova Scotia from 13F filings

Historical chart of Bank of Nova Scotia investment in Amylyx Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Amylyx Pharmaceuticals held by Bank of Nova Scotia consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Amylyx Pharmaceuticals by Bank of Nova Scotia

Quarter filed Position value Share count Share price at filing
2024-09-30 $35k 11k 3.24

More positions owned by Bank of Nova Scotia

NVIDIA Corporation (NVDA)
Microsoft Corporation (MSFT)
Apple (AAPL)
Toronto Dominion Bk Ont Com New (TD)
Rbc Cad (RY)
Cibc Cad (CM)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Bank Of Montreal Cadcom (BMO)
Enbridge (ENB)
Amazon (AMZN)
Tc Energy Corp (TRP)
Meta Platforms Cl A (META)
Broadcom (AVGO)
Alphabet Cap Stk Cl A (GOOGL)
Ishares Tr Core S&p500 Etf (IVV)

View all positions for Bank of Nova Scotia

Top funds holding Amylyx Pharmaceuticals

Vanguard Group
BlackRock
Goldman Sachs Group
BlackRock
Citadel Advisors
Perceptive Advisors
Alyeska Investment Group
683 Capital Management
Almitas Capital
Standard Life Aberdeen
Acadian Asset Management
Nantahala Capital Management
Two Sigma Investments
Two Sigma Advisers
Farallon Capital Management

View all funds holding Amylyx Pharmaceuticals